Navigation Links
Spirus Medical Announces Japanese Regulatory Approval to Market ENDO-EASE® Product Line

STOUGHTON, Mass., Sept. 8 /PRNewswire/ -- Spirus Medical announced today that it has obtained marketing approval from the Japanese Ministry of Health, Labor and Welfare for the company's proprietary ENDO-EASE line of endoscopy devices. The Endo-Ease Endoluminal Advancement System features novel "over-tubes" that use a spiral design utilizing simple rotation to facilitate enteroscopy, colonoscopy and ileoscopy.

According to Spirus Medical, the Endo-Ease line is well suited for the Japanese endoscopy marketplace, which emphasizes in-hospital treatment.  The Endo-Ease allows both visualization and, if needed, appropriate treatment of gastrointestinal disease. Competing new platforms, such as ingestible "pill cameras", provide only detection, and are administered on an outpatient basis. Endoscopic treatment, under those regimens, needs to be scheduled for a second, in-hospital procedure.

Century Medical, Inc. (CMI), one of Japan's largest independent medical device distributors, has over 150 sales representatives throughout the country to serve one of the largest endoscopic markets in the world. Spirus first announced the partnership in October, 2009. "The approval is an important success for Spirus Medical and CMI's regulatory affairs teams, and will now allow CMI's extensive sales & marketing network to introduce the ground-breaking devices into Japan. We anticipate that the clinical benefits of the Endo-Ease will prove to be highly appealing to health care providers and their patients throughout Japan," said Robert Ailinger, Spirus Medical's Chief Operations Officer.

"We are pleased to be partnering with Spirus Medical, and we look forward to expanding awareness and adoption of the company's innovative technologies," said Akira Hoshino, President  & CEO of CMI.

"We foresee a highly productive collaboration with CMI as we work to further extend the applications and value of the Endo-Ease platform technology," said Steven J. Tallarida, President and CEO of Spirus Medical. "With several applications already developed in gastroenterology, and additional ones planned for future markets, we look forward to working with CMI to provide benefits for both the endoscopist and their patients."

Spirus Medical, Inc.

Spirus Medical is a leader in bringing novel innovations to the GI market. The company pioneered the concept of "spiral endoscopy" with the introduction of the Endo-Ease Discovery ® SB for deep enteroscopy and the Vista® Retrograde for colonoscopy and ileoscopy. These rotate-to-advance technologies utilize a spiral element on an over-tube to advance and anchor medical devices in natural orifices of the body or a surgically created opening. The company is presently developing a flexible endoscope with an integral drive to power a single use spiral component. For more information on Spirus Medical, visit

SOURCE Spirus Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Spirus Medical Announces Complete Examinations of the Small Intestine by Physicians Using Endo-Ease(TM)
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Globus Medical Raises $110 Million in Series E Financing Round
6. Quark Pharmaceuticals Appoints New Chief Medical Officer
7. Boston University Biomedical Engineers Find Chink in Bacterias Armor
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
10. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
11. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
Post Your Comments:
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):